[ {"question": "What does the PHS Act section 2719 require non-grandfathered group health plans and health insurance issuers to provide?", "answer": "relevant notices in a culturally and linguistically appropriate manner"}, {"question": "What is the minimum percentage of people literate in a county?", "answer": "people who are literate only in the same non-English language"}, {"question": "What is the threshold percentage set at?", "answer": "10 percent or more of the population residing in the claimant\u2019s county"}, {"question": "How many C.F.R.  54.9815-2719T?", "answer": "26"}, {"question": "What section of the PHS Act requires group health plans and health insurance issuers to provide in a culturally and linguistically appropriate manner?", "answer": "Section 2715"}, {"question": "The regulations implementing section 2715 adopt the ten percent threshold set forth in what?", "answer": "section 2719"}, {"question": "How many C.F.R.  54.9815-2715?", "answer": "26"}, {"question": "What is the threshold for counties that meet or exceed the 10 percent threshold for the 2010-2014 ACS data?", "answer": "10 percent threshold"}, {"question": "When does HHS expect to issue guidance identifying the non-English languages that are triggered by these standards?", "answer": "February 2016"}, {"question": "How many top 15 languages are spoken by LEP populations in most states?", "answer": "15"}, {"question": "What is a language spoken by at least 10 percent of the population in a claimant's county?", "answer": "Navajo"}, {"question": "What does Section 1557 of the Affordable Care Act do?", "answer": "provide information in an accessible manner to individuals with limited English proficiency"}, {"question": "What must QHP issuers include in their summaries of benefits and coverage?", "answer": "an addendum with language taglines in the top 15 languages spoken by the LEP populations of that state"}, {"question": "When was the American Community Survey?", "answer": "20 10-2014"}, {"question": "When was the 20 10-2014 data released?", "answer": "December 3, 2015"}, {"question": "When does CMS anticipate releasing the list?", "answer": "December or the following January of each year"}, {"question": "How many Marketplaces are there?", "answer": "2"}, {"question": "What may also be included in this addendum?", "answer": "taglines required under Public Health Service Act 2715 and its implementing regulations"}, {"question": "What must the addendum only include?", "answer": "tagline information required by language access standards for critical documents"}, {"question": "Counties may have been added or removed based on what?", "answer": "changes in the data"}, {"question": "What is the percentage of Chinese people in Alabama?", "answer": "10%"},
 {"question": "Who is the Director of the Center for Consumer Information & Insurance Oversight?", "answer": "Randy Pate"}, {"question": "What is CMS providing to allow health insurance i ssuers in the individual and small group markets to temporarily offer premium credits for 2020?", "answer": "continuity of coverage"}, {"question": "The contents of this document do not have the force and effect of what?", "answer": "law"}, {"question": "What is the purpose of this document?", "answer": "to provide clarity to the public regarding existing requirements under the law"}, {"question": "Who was HHS Secretary on January 31, 2020?", "answer": "Alex M."}, {"question": "Who declared that as of January 27, 2020, a public health emergency exists nationwide as the result of the 2019 novel coronavirus?", "answer": "Azar II"}, {"question": "Who determines that a Public Health Emergency Exists?", "answer": "HHS Secretary"}, {"question": "On what date did the HHS Secretary renew the COVID -19 public health emergency declaration?", "answer": "April 21, 2020"}, {"question": "What is the name of the emergency page?", "answer": "https://www.phe.gov/emergency/new s/healthactions/phe/Pages/covid19 - 21apr2020.aspx"}, {"question": "When did the President declare the outbreak of COVID -19?", "answer": "March 13, 2020"}, {"question": "What does COVID stand for?", "answer": "Novel Coronavirus Disease"}, {"question": "Temporary 2020 Premium Credits Issuers are generally not permitted under what?", "answer": "federal law and regulations to reduce premiums that are otherwise due"}, {"question": "What is the urgent need to help individuals and small employers experiencing economic hardship maintain continuous coverage throug h the COVID -19 public health emergency?", "answer": "CMS will adopt a policy of relaxed enforcement with respect to 45 CFR 147.102, 155.200(f)(4) , 155.400(e) and (g)"}, {"question": "What does CMS encourage states to do?", "answer": "adopt a similar approach"}, {"question": "Who is the primary enforcer of the applicable federal requirements?", "answer": "CMS"}, {"question": "What must Issuers wishing to provide premium credits for 2020 receive in advance of providing premium credits?", "answer": "the applicable regulator\u2019s permission to provide premium credits"}, {"question": "What must issuers indicate in their requests to provide these credits?", "answer": "the fixed percentage by which they intend to provide credits against 2020 premium amounts and the month(s) in 2020 to which the credit s would apply"}, {"question": "What must be offered uniformly in a non- discriminatory manner to all members in a market in a state?", "answer": "fixed percentage credit"}, {"question": "What must a premium credit begin on?", "answer": "the first day of a month"}, {"question": "What can only be applied prospectively to future month(s) of 2020 coverage?", "answer": "premium credits"}, {"question": "What may not be used to reduce the amount QHP issuers collect from enrollees for coverage of non -Hyde abortion services?", "answer": "premium credits"}, {"question": "What must QHP issuers continue to comply with?", "answer": "all applicable requirement s pursuant to section 1303 of the PPACA"}, {"question": "Who is the primary enforcer of the applicable f ederal requirements in Missouri Oklahoma, Texas, and Wyoming?", "answer": "CMS"}, {"question": "Who intends to coordinate with state regulators in these states for premium credit requests?", "answer": "CM S"}, {"question": "What is 146.121?", "answer": "45 CFR"}, {"question": "What do CMS regulations govern?", "answer": "Medical Loss Ratio (MLR) reporting"}, {"question": "What would issuers of risk adjustment covered plans that elect to provide these credit s report?", "answer": "the full premium amounts for purposes of 2020 benefit year data submission for the HHS -operated risk adjustment program"}, {"question": "What does CMS intend to clarify in future rulemaking?", "answer": "MLR and risk adjustment report ing requirements"}, {"question": "What does FFE stand for?", "answer": "Federally -facilitated Exchange"}, {"question": "Who must submit the templates to notify CMS of all planned temporary premium credits for FFE or SBE -FP QHPs no later than October 1, 2020?", "answer": "Issuers"}, {"question": "To ensure proper allocation of APTC to the portion of premium that covers essential health benefits, what will CMS adjust in its enrollment data?", "answer": "premium and APTC amounts"}, {"question": "What will CMS report to the IRS?", "answer": "the adjusted premium and APTC amounts"}, {"question": "What does HealthCare.gov display for issuers' plans in states with an FFE or SBE -FP?", "answer": "Display of Premiums and Eligibility for Catastrophic Plans"}, {"question": "What does CMS stand for?", "answer": "Paperwork Reduction Act"}, {"question": "What does CMS seek OMB approval for?", "answer": "template and any new data elements not covered by PRA package CMS -10592"}, {"question": "CMS will not solicit or collect responses to the information collection request until approved by what?", "answer": "OMB"}, {"question": "How many premiums are without the application of any premium credits for the purpose of calculating the maximum APTC amount?", "answer": "4 premiums"}, {"question": "What will CMS adjust in its enrollment data to reflect premium credits for new enrollees?", "answer": "premium amounts and APTC amounts"}, {"question": "What does 45 CFR 156.50(c) specify?", "answer": "a participating issuer offering a plan through an FFE or SBE\u2013FP must remit a user fee to HHS each month that is equal to the product of the annual user fee rate specified in the annual HHS notice of benefit and payment parameters for FFEs and SBE\u2013FPs for the applicable benefit year and the monthly premium charged by the issuer for each policy where enrollment is through an FFE or SBE\u2013FP"}, {"question": "What will HHS calculate the 2020 benefit year user fees based on?", "answer": "monthly billed premium amount"}, {"question": "When was the 2020 Payment Notice published?", "answer": "April 25, 2019"}, {"question": "What are SBEs?", "answer": "Premium Credits on State -based Exchanges"}, {"question": "Under what type of reg.?", "answer": "Treas. Reg."}, {"question": "What must Exchanges report to the IRS and to individuals enrolled in a QHP?", "answer": "the monthly premiums for the plan in which the individual enrolled"}, {"question": "Who have advised CMS that Exchanges should report the monthly premium amount that includes application of the premium credit provided by the issuer?", "answer": "The IRS and the Treasury Department"}, {"question": "What does Treas. Reg. 1.36B do?", "answer": "-3(d)(1)(i)"}, {"question": "What must issuers in FFE and SBE -FP states wishing to offer these credits complete?", "answer": "template"}, {"question": "What should Issuers reach out to for additional information?", "answer": "CMS"}, {"question": "What should Temporary 2020 Premium Credits be in the subject line of your request?", "answer": "Temporary 2020 Premium Credits"},
  {"question": "What does FFCRA stand for?", "answer": "Families First Coronavirus Response Act"}, {"question": "Who has prepared the FAQs?", "answer": "Departments of Labor, Health and Human Services (HHS), and the Treasury (collectively, the Departments)"}, {"question": "Where are the FAQs available?", "answer": "https://www.dol.gov/agencies/ebsa/laws- and- regulations/laws/affordable -care- act/for -employers -and- advisers/aca- implementation -faqs"}, {"question": "When was the FFCRA enacted?", "answer": "March 18, 2020"}, {"question": "What is Pub. L. No. 116 -12 7?", "answer": "2020"}, {"question": "Who declared that as of January 27, 2020, a public health emergency exists nationwide as the result of the 2019 novel coronavirus?", "answer": "Azar II"}, {"question": "What is the HHS Office of the Assistant Secretary for Preparedness and Response called?", "answer": "Dete rmination of the HHS Secretary that a Public Health Emergency Exists"}, {"question": "When did the HHS Secretary renew the COVID -1 9 public health emergency declaration?", "answer": "Janua r y 14, 2022"}, {"question": "Who is responsible for the Renewal of Determination That A Public Health Emergency Exists?", "answer": "HHS Office of the Assistant Secretary for Preparedness and Response"}, {"question": "Who may extend the public health emergency declaration for subsequent 90 -da y periods?", "answer": "The HHS Secretary"}, {"question": "Who sent a letter to governors on January 22, 2021?", "answer": "Norris Cochran"}, {"question": "When was the CARES Act enacted?", "answer": "March 27, 2020"}, {"question": "What is the date of L. No. 116 -136?", "answer": "2020"}, {"question": "What is Section 3202(a) of the CARES Act?", "answer": "requires plans and issuers providing coverage to reimburse a provider that has a negotiated rate with the plan or issuer for COVID-19 diagnostic testing an amount that equals that negotiated rate"}, {"question": "What does the plan or issuer negotiate with the provider that is lower than the cash price?", "answer": "a rate"}, {"question": "What does section 6001 of the FFCRA inc l ude?", "answer": "amendments made by section 3201 of the CARES Act"}, {"question": "Under what section of the FFCRA are Departments authorized to implement the requirements of section 6001?", "answer": "section 6001(c)"}, {"question": "What does APA stand for?", "answer": "Administrative Procedure Act"}, {"question": "When is the FAQs about Families First Coronavirus Response Act and Coronavirus Aid, Relief, and Economic Security Act Implementation Part 43?", "answer": "June 23, 2020"}, {"question": "When is Affordable Care Act Implementation Part 50?", "answer": "26"}, {"question": "When is Affordable Care Act Implementation Part 51?", "answer": "January 10, 2022"}, {"question": "What is 553(b)(A)?", "answer": "6 5 U.S.C."}, {"question": "When was the Proclamation on Declaring a National Emergency Concerning the Coronavirus Disease 2019 (COVID- 19) Outbreak enacted?", "answer": "March 13, 2020"}, {"question": "When did the Departments issue FAQs about Affordable Care Act Implementation Part 51?", "answer": "January 10, 2022"}, {"question": "What must plans and issuers provide without cost- sharing requirements, prior authorization, or other medical management requirements?", "answer": "coverage for such tests"}, {"question": "What does EBSA stand for?", "answer": "-ebs a/our -activities/resource -center/faqs/aca- part- 51.pdf"}, {"question": "What Part 51 states that OTC C OVID -19 tests include those that can be self -administered and self -read at home or elsewhere without the involvement of a health care provider?", "answer": "Part 51"}, {"question": "How many safe harbors did F AQs Part 51 establish?", "answer": "two"}, {"question": "What is the name of the act that provides assistance to the United States?", "answer": "Assistance Act"}, {"question": "What section of the PHS Act states that a national emergency exists nationwide as a result of the COVID -19 pandemic?", "answer": "5121 et seq."}, {"question": "When did the World Health Organization designate the Omicron variant as a Variant of Concern?", "answer": "November 26, 2021"}, {"question": "On what date did the Centers for Disease Control and Prevention say the Omicron variant likely would spread more easily than the original SARS -CoV -2 virus?", "answer": "December 20, 2021"}, {"question": "What is the URL for coronavirus/2019?", "answer": "https://www.cdc.gov/coronavirus/2019 -n cov/variants/omicron -variant.html"}, {"question": "What are some OTC COVID -19 tests sold in?", "answer": "packages containing more than one test"}, {"question": "What must a plan limit reimbursement for OTC COVID -19 tests from?", "answer": "$12 per test"}, {"question": "What will the Departments not take enforcement action related to?", "answer": "coverage of OTC COVID-19 tests purchased without an order or individualized clinical assessment by a health care provider"}, {"question": "What does the D epartments note that the 30-day period may be?", "answer": "a rolling 30-day period"}, {"question": "How many questions have Departments received from stakeholders regarding FAQs Part 51?", "answer": "a number of questions"}, {"question": "FAQs Part 52 modify what?", "answer": "the safe harbor"}, {"question": "What do plan s and issuers have to establish in order to qualify for the safe harbor?", "answer": "a direct -to-consumer shipping program and direct coverage through a n in- person network"}, {"question": "What are the requirements of the safe harbor established in?", "answer": "FAQs Part 51, Q2"}, {"question": "How many direct- to-consumer shipping mechanisms are there for OTC COVID -19 tests?", "answer": "at least one"}, {"question": "What does the price of tests include when providing coverage of OTC COVID -19 tests outside of a direct coverage pathway?", "answer": "shipping and sales tax costs related to the purchase of OTC COVID -19 tests"}, {"question": "What does a direct coverage program provide?", "answer": "adequate access"}, {"question": "What does a small employer's plan cover?", "answer": "employees who live and work in a localized area"}, {"question": "What is an example of a standalone drive-thr ough or walk-up distribution site?", "answer": "a standalone drive-thr ough or walk-up distribution site"}, {"question": "What should participants, beneficiaries, and enrollees know?", "answer": "key information needed to access OTC COVID -19 testing"}, {"question": "What is a direct-to-consumer shipping mechanism?", "answer": "any program that provides direct coverage of OTC COVID-19 test s for participants , beneficiaries, or enrollees without requiring the individual to obtain the test at an in-person location"}, {"question": "What can a direct-to-consumer shipping mechanism include?", "answer": "online or tele phone ordering"}, {"question": "What does a direct-to-consumer shipping program not have to provide?", "answer": "exclusive access through one entity"}, {"question": "What does the Departments consider a plan or issuer to have provided if it provides direct in-person coverage of OTC COVID-19 tests through specified retailers?", "answer": "a direct -to-consumer shipping mechanism"}, {"question": "Who must cover reasonable shipping costs when providing OTC COVID-19 tests through a direct- to-consumer shipping program?", "answer": "plans and issuers"}, {"question": "What must a plan or issuer ensure when implementing a n in-person mechanism?", "answer": "that participants, beneficiaries, or enrollees have access to OTC COVID -19 tests through an adequate number of locations"}, {"question": "What did the Departments note in FAQs Part 51, Q2?", "answer": "whether there is adequate access should be determined based on all relevant facts and circumstances, such as the locality of participants, beneficiaries, or enrollees under the plan or coverage"}, {"question": "Who do the Departments request information from to ensure that participants, beneficiaries, and enrollees have adequate access to OTC COVID -19 tests?", "answer": "plans and issuers"}, {"question": "What does not require a plan or issuer to make all OTC COVID -19 tests available to its participants, beneficiaries, or enrollees through its direct coverage program?", "answer": "Adequate access"}, {"question": "What must a plan or issuer cover to meet the statutory criteria?", "answer": "all OTC COVID -19 tests that meet the statutory criteria under section 6001(a)(1) of the FFCRA"}, {"question": "How does the guidance in the Q1 guidance apply?", "answer": "prospectively"}, {"question": "What do the Departments take against a plan or issuer that is temporarily unable to provide adequate access to OTC COVID -19 tests through its direct coverage program?", "answer": "enforcement action"}, {"question": "What will a Department not consider a plan or issuer to be out of compliance with?", "answer": "the safe harbor in FAQ Part 51, Q2"}, {"question": "What is the maximum reimbursement for OTC COVID-19 tests purchased outside of the direct coverage program?", "answer": "$12 per test"}, {"question": "What must a consumer do if they are able to obtain eligible tests despite a supply shortage?", "answer": "reimburse the participant, beneficiary, or enrollee for at least 8 tests per 30 -day period (or per month)"}, {"question": "Is a plan or issuer permitted to address suspected fraud and abuse related to the reimburse ment of OTC COVID-19 tests purchased by a participant, beneficiary, or enrolle e from a private individual or via online auctions, resale marketplaces, or resellers?", "answer": "Yes"}, {"question": "What does the FFCRA prohibit?", "answer": "medical management of coverage of COVID -19 diagnostic testing"}, {"question": "What could limit access to consumers?", "answer": "problematic behaviors"}, {"question": "Who may disallow reimbursement for tests that are purchased by a participant, beneficiary, or enrollee?", "answer": "plans and issuers"}, {"question": "What could a policy require?", "answer": "documentation of proof of purchase that clearly identifies the product and seller, such as a UPC code or other serial number, original receipt from the seller of the test, or other documentation for the OTC COVID-19 test to verify that the item qualifies for coverage under section 6001 of FFCRA, or a requirement that the participant, beneficiary, or enrollee attest that the test has not 7 been (and will not be) reimbursed by another source"}, {"question": "What should a plan or issuer provide if it disallows reimbursement for OTC C OVID-19 tests from certain resellers?", "answer": "general information about the types of resellers for which participants, beneficiaries, and enrollees are not eligible for reimbursement of purchased tests under the plan or coverage"}, {"question": "What part of FAQs Part 51, Q4 prohibits a plan or issuer from requiring individuals to submit multiple documents?", "answer": "FAQs Part 51, Q4"}, {"question": "What does Part 51 of the FAQs apply to?", "answer": "COVID- 19 tests that use a self -collected sample but require processing by a laboratory or other health care provider to return results"}, {"question": "What applies to OTC COVID-19 tests that are approved, cleared, or authorized for use by the Food and Drug Administration?", "answer": "The guidance in FAQs Part 51"}, {"question": "What is not applicable to an OTC COVID-19 test?", "answer": "guidance in FAQs Part 51 and these FAQs Part 52"}, {"question": "What did 17 FAQs Part 51 refer to these tests as?", "answer": "self -t ests or at -home tests"}, {"question": "What is the cost of OTC COVID-19 tests?", "answer": "a medical expense"}, {"question": "What do FAQs Part 51, Q1 and Q2 require?", "answer": "plans and issuers to cover OTC COVID -19 tests"}, {"question": "How many times can an individual not be reimbursed for the same medical expense?", "answer": "more than once"}, {"question": "What cannot be reimbursed by a health FSA or HRA?", "answer": "the cost (or the portion of the cost) of OTC COVID- 19 tests"}, {"question": "Who may wish to advise individuals not to seek reimbursement from a health FSA or HRA for the cost of OTC COVID- 19 tests paid or reimbursed by the plan or issuer?", "answer": "plans and issuers"}, {"question": "What should an individual do if they receive reimbursement 8 from a health FSA or HRA for OTC COVID- 19 test costs?", "answer": "contact the health FSA or HRA administrator"}, {"question": "What is not included in gross income if the distribution is used to pay for qualified medical expenses?", "answer": "a distribution from an individual\u2019s health savings account (HSA)"}, {"question": "What section of the Code defines qualified medical expenses?", "answer": "223(d)(2)"}, {"question": "What happens if an individual mistakenly takes a distribution from an HSA for OTC COVID-19 test costs paid or reimbursed by a plan or issuer?", "answer": "the individual must either (1) include the distribution in gross income, or (2) if a nd as permitted under Q&A-37 and -76 of IRS Notice 2004-50, repay the distribution to the HSA"},
   {"question": "What does CCIIO stand for?", "answer": "Clinical Laboratory Improvement Amendments"}, {"question": "What did CMS issue today?", "answer": "a sweeping array of new rules and waivers of federal requirements"}, {"question": "What did CMS do to help facilitate the nation\u2019s response to the COVID-19 pandemic?", "answer": "announced the adoption of certain temporary policies of relaxed enforcement for all issuers offering health insurance coverage in the individual and small group markets to support continuity of coverage for individuals, families and small employers who may struggle to pay premiums because of illness or loss of incomes or revenue resulting from the public health emergency for COVID-19."}, {"question": "When did CMS announce a policy allowing issuers to offer temporary premium reductions?", "answer": "August 4, 2020"}, {"question": "What does MLR stand for?", "answer": "Medical Loss Ratio"}, {"question": "What does the rulemaking specify for the purposes of 2020 benefit year risk adjustment data submissions?", "answer": "issuers of risk adjustment covered plans that provide temporary premium reductions must report the adjusted plan premiums that reflect actual premiums billed to enrollees for any temporary premium credits provided"}, {"question": "What will HHS's calculation of risk adjustment payment and charges for the 2020 benefit year under the state payment transfer formula use?", "answer": "the statewide average premium"}, {"question": "What does the rulemaking clarify for the purposes of MLR reporting and rebates?", "answer": "issuers that elect to provide temporary premium reductions must report as earned premium the actual, lower premium billed to enrollees for any temporary premium credits provided for the applicable months of 2020 coverage."},
     {"question": "The contents of this document do not have the force and effect of what?", "answer": "law"}, {"question": "What is the purpose of this document?", "answer": "to provide clarity to the public regarding existing requirements under the law"}, {"question": "What is part 54 of the Affordable Care Act?", "answer": "J uly 28, 2022"}, {"question": "Who has prepared the FAQs?", "answer": "Departments of Labor, Health and Human Services (HHS), and the Treasury (collectively, the Departments)"}, {"question": "What do these FAQs answer?", "answer": "to help people understand the law and promote complia nce"}, {"question": "What is the CO VERAGE of PREVENTIVE SERVICES Act section 2713?", "answer": "P ublic Health Service (PHS) Act"}, {"question": "What is section 3203 of?", "answer": "Coronavirus Aid, Relief, and Economic Security (CARES) Act"}, {"question": "What does the term \"qualifying coronavirus preventive service\" mean?", "answer": "an item, service, or immunization that is intended to prevent or mitigate coronavirus disease 2019 (C OVID- 19)"}, {"question": "When did the Departments publish interim final rules with a request for comment regarding this requirement?", "answer": "November 6, 2020"}, {"question": "What did the USPSTF publish in January 2016?", "answer": "updated breast cancer screening recommendations"}, {"question": "What is section 223 of?", "answer": "Division H of the Consolidated Appropriations Act, 2021"}, {"question": "What section of the PHS Act requires that USPSTF recommendations relating to breast cancer screening, mammography, and prevention issued before 2009 remain in effect until January 1, 2023?", "answer": "PHS Act section 2713"}, {"question": "What does HRSA stand for?", "answer": "Health Resources and Services Administration"}, {"question": "What may a plan or issuer rely on to determine the frequency, method, treatment, or setting for coverage of a recommended preventive health item or service?", "answer": "relevant clinical evidence base and established reasonable medical management techniques"}, {"question": "When did HRSA accept updates to the existing guidelines regarding breastfeeding services and supplies?", "answer": "December 30, 2021"}, {"question": "What is the 26 CFR 54.9815?", "answer": "2713(a)(4)"}, {"question": "What does 85 FR 71142, 71174 say?", "answer": "Nov. 6, 2020"}, {"question": "Who approves, clears, and grants contraceptive products?", "answer": "the FDA"}, {"question": "What is the name of the guideline for women?", "answer": "https://www.hrsa.gov/womens -guidelines -2019"}, {"question": "When is the hrsa released?", "answer": "11, 2022"}, {"question": "What must a non- exempt10 plan or issuer subject to provide coverage pursuant to?", "answer": "26 CFR 54.9815-2713(a)(1), 29 CFR 2590.715-2713(a)(1), and 45 CFR 147.130(a)(1)"}, {"question": "What must a plan or issuer provide in the event of changes in recommendations or guidelines?", "answer": "coverage through the last day of the plan or policy year"}, {"question": "What is the contraceptive coverage requirement under PHS Act 2713?", "answer": "guidance provided in these FAQs"}, {"question": "What should be understood to include both the 2019 HRSA-Supported Guidelines and the 2021 HRSA-Supported Guidelines?", "answer": "References in this document to the HRSA -Supported Guidelines"}, {"question": "When did the Departments issue an FAQ?", "answer": "January 10, 2022"}, {"question": "What did the FAQ remind plans and issuers that are subject to the contraceptive coverage requirements of?", "answer": "their responsibility to fully comply with the requirements of PHS Act 10"}, {"question": "When did the Departments issue FAQs about Part 48 of the Affordable Care Act?", "answer": "August 16, 2021"}, {"question": "What do references to plans and issuers throughout these FAQs refer to?", "answer": "plans and issuers that are not exempt from the requirement to coverage contraceptive services and products without cost sharing"}, {"question": "What is the 26 CFR 54.9815- 2713(b)?", "answer": "26 CFR 54.9815- 2713(b)"}, {"question": "What section of the PHS Act does a recommendation or guideline in the comprehensive guidelines supported by HRSA fall under?", "answer": "section 2713"}, {"question": "How many FR 41726, 41729 were issued on July 19, 2010?", "answer": "75"}, {"question": "What is Part 51 of the Affordable Care Act?", "answer": "Families First Coronavirus Response Act"}, {"question": "What is Part 51 of theACA?", "answer": "Affordable Care Act Implementation Part XII"}, {"question": "When was Affordable Care Act Implementation Part XXVI released?", "answer": "May 11, 2015"}]